Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
NADH:ubiquinone oxidoreductase subunit B8 pseudogene 2 (NDUFB8P2) is annotated as a human pseudogene, related to the protein-coding gene NDUFB8, which encodes a non-catalytic accessory subunit of mitochondrial complex I (NADH dehydrogenase (ubiquinone) 1 beta subcomplex subunit 8)[2][4][5]. NDUFB8P2 itself is *not* known to express a functional protein and is not involved in mitochondrial respiratory chain activity or disease mechanisms. This distinguishes it from the closely related NDUFB8 gene, which is protein-coding and associated with mitochondrial function. There is no evidence for NDUFB8P2 being a therapeutic target, biomarker, or participant in drug interaction networks[5][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on NADH:ubiquinone oxidoreductase subunit B8 pseudogene 2 (NDUFB8P2).